false
OasisLMS
Catalog
SCCM Resource Library
Beyond Procalcitonin: Emerging Biomarkers for Seps ...
Beyond Procalcitonin: Emerging Biomarkers for Sepsis
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, the speaker discusses the potential role of biomarkers in sepsis. They explain that biomarkers can be used to help with diagnosis, determine the type of infection (bacterial or viral), guide antibiotic use, predict prognosis, and decide on the site of care. The speaker highlights the biomarker procalcitonin, which has been extensively studied and has shown promise in guiding the duration of antibiotic therapy. They also mention other biomarkers such as pancreatic stone protein, pentraxin, and presepsin, which are being studied for their potential use in sepsis. The speaker emphasizes the importance of using multiple biomarkers in combination with clinical assessment, as no single biomarker can provide all the necessary information. They also discuss the potential use of biomarkers in managing patients with COVID-19 and reducing unnecessary antibiotic use. Overall, biomarkers have the potential to improve sepsis management, but more research is needed to fully understand their role.
Asset Subtitle
Sepsis, 2023
Asset Caption
Type: one-hour concurrent | Challenges in Sepsis Prediction and Prognosis (SessionID 1228529)
Meta Tag
Content Type
Presentation
Knowledge Area
Sepsis
Membership Level
Professional
Membership Level
Select
Tag
Sepsis
Year
2023
Keywords
biomarkers
sepsis
diagnosis
antibiotic therapy
procalcitonin
×
Please select your language
1
English